BioNexus Gene Lab Corp's total assets for Q3 2025 were $7.62M, a decrease of -19.11% from the previous quarter. BGLC total liabilities were $804.97K for the fiscal quarter, a -57.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.